Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; CK; cytokeratins; BC; breast cancer; HER-2; human epidermal growth factor receptor-2; RT-PCR; reverse transcription followed by polymerase chain reaction; BBD; benign breast diseases; TNM; Classification of Malignant Tumors; ER; estrogen receptor; SBR; Sc
مقالات ISI گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; AP-1; activator protein-1; Bax; Bcl-2-associated X protein; Bcl-2; B cell lymphoma-2; CCl4; carbon tetrachloride; COX-2; cyclooxigenase-2; EGF; epidermal growth factor; ELAM-1; endothelial leukocyte adhesion molecule-1; FGF; fibroblast growth factor; GnRH
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; AAV; adeno-associated viruses; ADA; adenosine deaminase deficiency; APCs; antigen presenting cells; AuNC; gold nanoclusters; AuNPs; gold nanoparticles; AuNRs; gold nanorods; BBB; blood-brain barrier; Bcl-2; B-cell lymphoma 2; Cas; CRISPR-associated; ChNPs
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ABC; Accelerated blood clearance; BBB; Blood brain barrier; CH; Cholesterol; CHEMS; Cholesteryl hemisuccinate; DOPE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DPPC; 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DPPG2; 1,2-dipalmitoyl-sn-glycero-3-phos
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Breast cancer; Estrogen receptor; Endocrine resistance; Human epidermal growth factor receptor-2; mTOR; CDK 4/6 inhibitors;
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; lapatinib; paclitaxel; poorly water-soluble drugs; solubility; micelle; cancer chemotherapy; sensitize; human epidermal growth factor receptor-2; polymeric drug delivery systems; conjugation;
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; 18F-FAZA; 18F-labeled fluoroazomycin arabinoside; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-HX4; 18F-labeled flortanidazole; 18F-MISO; 18F-labeled fluoromisonidazole; 62Cu-ATSM; 62Cu-labeled diacetyl-bis(N-methylth
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; AKT; a serine/threonine-specific protein kinase, also known as Protein Kinase B (PKB); CCS; charcoal-stripped fetal-calf serum; CSC; cancer stem cell; E2; 17β-estradiol; E2:ER; E2-bound estrogen receptor; EGFR; epidermal growth factor receptor; ER; estro
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; IGFs; insulin-like growth factors; SHBG; sex hormone binding globulin; BMI; body mass index; IGFBPs; IGF binding proteins; IGF-1R; insulin-like growth factor-1 receptor; CLS; crown-like structure; NFκB; nuclear factor kappa-B; STAT3; signal transducer an
CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; GC; gastric cancer; CDH17; cadherin-17; CDH; cadherin; siRNA; short-interfering RNA; MMP2; matrix metallopeptidase 2; NF-κB; nuclear factor-kappaB; HER2; human epidermal growth factor receptor-2; EGFR; epidermal growth factor receptor; PI3K/AKT/mTOR; pho
Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ACBD3; Acyl-CoA binding domain containing 3; ER; estrogen receptor; PR; progesterone receptor; Her2; human epidermal growth factor receptor-2; CSC; cancer stem cell; BCSC; breast cancer stem cell; EGFR; epidermal growth factor receptor; ACBP; acyl-CoA-bin
The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Breast cancer; HER2; Neoadjuvant; Network meta-analysis; Dual-HER2 blockade; Human epidermal growth factor receptor-2;
Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; DA; dominant active; DN; dominant negative; DCIS; ductal carcinoma in situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ERK; extracellular-signal regulated kinase; ER; estrogen receptor; GAP; GTPase activating protein; GFP; green
Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; TNBC; Triple-negative breast cancer; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor-2; EMT; epithelial-mesenchymal transition; BMI1; B-lymphoma Moloney murine leukemia virus insertion region-1; ZEB1; zing fi
Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ER; estrogen receptor; GK; ginkgetin; Her-2; human epidermal growth factor receptor-2; MAPKs; mitogen-activated protein kinases; p-ERK; phospho extracellular-related kinase; p-JNK; phospho Jun-amino-terminal kinase; PR; progesterone receptor; MTT; 3-[4,5-
New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Antiproliferative agents; Antitumor agents; Bis(hydroxymethyl) alkanoate curcuminoids; Curcumin; Triple-negative breast cancer; BUN; blood urea nitrogen; DMAP; N,N-dimethylaminopyridine; DMF; dimethylformamide; DMSO; dimethylsulfoxide; EtOAc; ethyl acetat
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer - An observational study prospectively recording resource utilization in a Swedish healthcare setting
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; HER2-positive breast cancer; Trastuzumab; Subcutaneous; Intravenous; Resource use; Societal cost; CPI; Consumer Price Index; HER2; Human Epidermal growth factor Receptor-2; IV; Intravenous; SC; Subcutaneous; SEK; Swedish Kronor; WTP; Willingness-to-Pay;
Epigallocatechin gallate and mitochondria-A story of life and death
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ADP; adenosine diphosphate; AIF; apoptosis-inducing factor; ALT; alanine aminotransferase; AMP; adenosine monophosphate; AP-1; activator protein-1; ASK1; apoptosis signal-regulating kinase 1; ATP; adenosine triphosphate; Bax; BCL2-Associated X Protein; Bc
Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with breast cancer treated with HER2 blockade
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Human epidermal growth factor receptor-2; Fatal adverse events; Meta-analysis;
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; AcP; acid phosphatase; AI; androgen-independent; AS; androgen-sensitive; cPAcP; cellular prostatic acid phosphatase; CR PCa; castration-resistant prostate cancer; DSP; dual specificity phosphatase; EGFR; epidermal growth factor receptor; HER-2/ErbB-2/neu;
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ER; estrogen receptor; PgR; progesterone receptor; HER2/erbB2; human epidermal growth factor receptor-2; E2; estradiol; RTK; receptor tyrosine kinase; IGF-IR; insulin-like growth factor I receptor; EGFR; epidermal growth factor receptor; MAPK; mitogen act
Nanomedicines in the future of pediatric therapy
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ACTs; artemisinin combined therapies; ALN; alendronate; ANMAT; Administración Nacional de Medicamentos, Alimentos y TecnologÃa Médica; ARV; antiretrovirals; AS; antisense; AUC; area-under-the-curve; BMS; burning mouth syndrome; CD; cytosine deaminase;
HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Ductal carcinoma in situ; Human epidermal growth factor receptor-2; Local recurrence; Breast-conserving treatment; Radiotherapy;
Personalized Oncology in Interventional Radiology
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ATP; adenosine triphosphate; ALK; analplastic lymphoma factor; BCR-ABL; breakpoint cluster region/the Abelson tyrosine; BRAF; v-raf murine sarcoma viral oncogene; CD-20; clusters of differentiation-20 (antigen of B-cells); c-KIT; tyrosine-protein kinase k
mTOR inhibitors in advanced breast cancer: Ready for prime time?
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Advanced breast cancer; Endocrine resistance; Estrogen receptor; Everolimus; Exemestane; Human epidermal growth factor receptor-2; mTOR inhibitor; Progesterone receptor
Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae - A review
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Bax; Bcl-2-associated x protein; Bcl-xL; B-cell lymphoma-extra large; Bcl-2; B-cell lymphoma 2; COX-2; cyclooxygenase-2; EGFR; epidermal growth factor receptor; ER-α; estrogen receptor-α; ERK; extracellular signal-regulated kinase; HER-2; human epiderma
Perspectives des thérapies ciblées dans le cancer du sein métastatique
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; thérapie ciblée; cancer du sein métastatique; HER-2; anti-angiogénèse; étude clinique; targeted therapy; metatstatic breast cancer; HER-2; anti-agiogenesis; clinical trial; ADCC; cytotoxicité à médiation cellulaire anticorps-dépendante; Akt; pro
Liposomal paclitaxel formulations
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Cr-P; paclitaxel solubilized in Cremophor EL®; DCP; dicetylphosphate; DEPC; dielaidoyl phosphatidyl choline; DLPC; dilauroyl phosphatidyl choline; DLPE; dilauroyl phosphatidyl ethanolamine; DLPG; dilauroyl phosphatidyl glycerol; DLTs; dose-limiting toxic
The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; ADAP; adhesion- and degranulation-promoting adapter protein; Carma1; caspase-recruitment domain [CARD]-membrane-associated guanylate kinase [MAGUK] protein 1; CDR3; complementary determining region 3; GM1; ganglioside M1; GC; gas chromatography; HER2; hum
Facteurs de risque de récidive des cancers du sein traités par chirurgie conservatrice : à propos de 254 cas
Keywords: گیرنده گیرنده فاکتور رشد اپیدرمی انسان 2; Cancer du sein; Récidive; Facteur de risque; Traitement conservateur; Breast cancer; Recurrence; Risk factor; Conserving therapy; CHU; centre hospitalo-universitaire; OR; odd ratio; FEC; 5 FU, epirubicine, cyclophosphamide; TNM; taille, statut ganglionna